Helius medical technologies, inc. announces pons® is now available on the veterans affairs (va) federal supply schedule (fss) and general services administration (gsa) advantage contracts

-- approval provides u.s. veterans and other u.s. government agency employees who suffer gait and balance impairment due to multiple sclerosis (ms) access to the only portable neurostimulation therapy with the potential to generate neuroplasticity -- newtown, pa., may 20, 2024 (globe newswire) -- helius medical technologies, inc. (nasdaq:hsdt) (“helius” or the “company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced the company's portable neuromodulation stimulator (pons®) device has been approved for inclusion on lovell government services' (“lovell”) veterans affairs (va) federal supply schedule (fss) and general services administration (gsa) advantage contracts.
FSS Ratings Summary
FSS Quant Ranking